Patents Assigned to UGISense AG
  • Chiral compounds substituted with phosphonic acid ester functions or phosphonic acid functions
    Patent number: 9951093
    Abstract: The present invention relates to novel compounds that contain PNA units substituted with phosphonic acid ester functions or phosphonic acid functions, and have at least one chiral center. The compounds may be used for the treatment of viral diseases, such as AIDS.
    Type: Grant
    Filed: June 19, 2012
    Date of Patent: April 24, 2018
    Assignee: UGISense AG
    Inventors: Thomas Lindhorst, Birgit Werner, Holger Bock